Consortium

Updated:

Medical Technology Enterprise Consortium

The Medical Technology Enterprise Consortium (MTEC) was established to bridge the gap between military medical needs and commercial medical technology...

Medical Technology Enterprise Consortium

The Medical Technology Enterprise Consortium (MTEC) was established to bridge the gap between military medical needs and commercial medical technology innovation. The consortium was founded under a cooperative agreement with the U.S. Army Medical Research and Development Command (USAMRDC), serving as a public-private partnership. MTEC focuses on funding and developing medical technologies across multiple areas: trauma care, infectious disease, surgical devices, and diagnostic tools. The consortium issues solicitations and awards contracts to member organizations, which include academic institutions, large defense contractors, and small startups. Notable members include the Mayo Clinic, the University of Texas Medical Branch, and companies like 3M and Battelle. MTEC's geographic reach extends across the United States through its member base. The consortium has awarded over 500 projects since its inception, with total funding exceeding $300M per USAMRDC data. MTEC operates with a small core team based in Buffalo, New York, and works through a network of member organizations. It does not disclose team size or internal AUM, as operations are financed through government contracts and member fees. A recent initiative in early 2025 focused on rapid development of battlefield hemorrhage-control devices. MTEC's structural differentiator is its consortium governance model: it acts as a central clearinghouse for defense-related medical technology funding, rather than a traditional family office or venture firm. This allows rapid deployment of government capital with reduced administrative overhead, while leveraging the research and manufacturing capacity of over 370 member organizations.

General information

Firm type

Consortium

Year founded

AUM

Undisclosed

Location

Region

North America

Country

United States

City

Buffalo

Corporate office

Buffalo, NY, United States

Sector focus

Healthcare ServicesDigital HealthIndustrial Tech

Frequently asked questions

How does MTEC fund medical technology development?

MTEC uses a cooperative agreement with the U.S. Army Medical Research and Development Command. It issues request-for-proposals (RFPs) to its member organizations, who then compete for contracts. Projects are funded by the Department of Defense, with MTEC serving as a managing entity.

Can for-profit companies join MTEC?

Yes—MTEC membership is open to for-profits, non-profits, academic institutions, and government entities. As of mid-2025, the consortium includes over 370 members, ranging from small med-tech startups to large defense contractors.

What medical technology areas does MTEC prioritize?

MTEC focuses on technologies relevant to military medicine: combat casualty care, infectious disease countermeasures, surgical procedures, diagnostics, and medical simulation. Recent solicitations have included point-of-care diagnostics, advanced wound care, and neural health monitoring.

Is MTEC a family office or investment firm?

No—MTEC is a nonprofit consortium established under a government cooperative agreement. Its structure is that of a granting entity and project manager for Department of Defense medical technology R&D, not an asset manager or family office.

How are MTEC's projects selected and managed?

Projects are driven by USAMRDC mission requirements. MTEC releases RFPs in designated focus areas; member organizations respond with proposals. Proposals are evaluated on technical merit, cost, and timeline, and awards are made through a competitive process.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on family offices?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo